These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 37127249)

  • 1. Targeting tyrosinase in hyperpigmentation: Current status, limitations and future promises.
    Zolghadri S; Beygi M; Mohammad TF; Alijanianzadeh M; Pillaiyar T; Garcia-Molina P; Garcia-Canovas F; Munoz-Munoz J; Saboury AA
    Biochem Pharmacol; 2023 Jun; 212():115574. PubMed ID: 37127249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4-n-butylresorcinol, a highly effective tyrosinase inhibitor for the topical treatment of hyperpigmentation.
    Kolbe L; Mann T; Gerwat W; Batzer J; Ahlheit S; Scherner C; Wenck H; Stäb F
    J Eur Acad Dermatol Venereol; 2013 Jan; 27 Suppl 1():19-23. PubMed ID: 23205541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Human Tyrosinase Requires Molecular Motifs Distinctively Different from Mushroom Tyrosinase.
    Mann T; Gerwat W; Batzer J; Eggers K; Scherner C; Wenck H; Stäb F; Hearing VJ; Röhm KH; Kolbe L
    J Invest Dermatol; 2018 Jul; 138(7):1601-1608. PubMed ID: 29427586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salidroside can target both P4HB-mediated inflammation and melanogenesis of the skin.
    Ding XJ; Zhang ZY; Jin J; Han JX; Wang Y; Yang K; Yang YY; Wang HQ; Dai XT; Yao C; Sun T; Zhu CB; Liu HJ
    Theranostics; 2020; 10(24):11110-11126. PubMed ID: 33042273
    [No Abstract]   [Full Text] [Related]  

  • 5. Natural Tyrosinase Inhibitors: Role of Herbals in the Treatment of Hyperpigmentary Disorders.
    Zaidi KU; Ali SA; Ali A; Naaz I
    Mini Rev Med Chem; 2019; 19(10):796-808. PubMed ID: 31244414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The hunt for natural skin whitening agents.
    Smit N; Vicanova J; Pavel S
    Int J Mol Sci; 2009 Dec; 10(12):5326-5349. PubMed ID: 20054473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The melanogenesis and mechanisms of skin-lightening agents--existing and new approaches.
    Gillbro JM; Olsson MJ
    Int J Cosmet Sci; 2011 Jun; 33(3):210-21. PubMed ID: 21265866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Pigmentation Effects of Eight
    Ahn HY; Choo YM; Cho YS
    J Microbiol Biotechnol; 2018 Mar; 28(3):375-380. PubMed ID: 29316744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functionality study of santalin as tyrosinase inhibitor: A potential depigmentation agent.
    Hridya H; Amrita A; Mohan S; Gopalakrishnan M; Dakshinamurthy TK; Doss GP; Siva R
    Int J Biol Macromol; 2016 May; 86():383-9. PubMed ID: 26828288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a hydroquinone-free skin brightening product using in vitro inhibition of melanogenesis and clinical reduction of ultraviolet-induced hyperpigmentation.
    Makino ET; Mehta RC; Banga A; Jain P; Sigler ML; Sonti S
    J Drugs Dermatol; 2013 Mar; 12(3):s16-20. PubMed ID: 23545928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical efficacy and safety of 4-hexyl-1,3-phenylenediol for improving skin hyperpigmentation.
    Won YK; Loy CJ; Randhawa M; Southall MD
    Arch Dermatol Res; 2014 Jul; 306(5):455-65. PubMed ID: 24402285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of new depigmenting compounds and their efficacy to treat hyperpigmentation: Evidence from in vitro study.
    Lajis AFB; Ariff AB
    J Cosmet Dermatol; 2019 Jun; 18(3):703-727. PubMed ID: 30866156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A split-face evaluation of a novel pigment-lightening agent compared with no treatment and hydroquinone.
    Draelos ZD
    J Am Acad Dermatol; 2015 Jan; 72(1):105-7. PubMed ID: 25440437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spherical Nucleic Acids for Topical Treatment of Hyperpigmentation.
    Fang Y; Lu X; Wang D; Cai J; Wang Y; Chen P; Ren M; Lu H; Union J; Zhang L; Sun Y; Jia F; Kang X; Tan X; Zhang K
    J Am Chem Soc; 2021 Jan; 143(3):1296-1300. PubMed ID: 33433203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Origanum essential oils reduce the level of melanin in B16-F1 melanocytes.
    El Khoury R; Michael-Jubeli R; Bakar J; Dakroub H; Rizk T; Baillet-Guffroy A; Lteif R; Tfayli A
    Eur J Dermatol; 2019 Dec; 29(6):596-602. PubMed ID: 31903949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melanogenesis inhibitory activity of two generic drugs: cinnarizine and trazodone in mouse B16 melanoma cells.
    Chang TS; Lin VC
    Int J Mol Sci; 2011; 12(12):8787-96. PubMed ID: 22272104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of isolates from Cassipourea flanaganii (Schinz) alston, a plant used as a skin lightning agent, on melanin production and tyrosinase inhibition.
    Langat MK; Dlova NC; Mulcahy-Ryan LE; Schwikkard SL; Opara EI; Crouch NR; Hiles JD; Mulholland DA
    J Ethnopharmacol; 2021 Jan; 264():113272. PubMed ID: 32810622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of melanin content by Punicalagins in the super fruit pomegranate (Punica granatum).
    Rana J; Diwakar G; Saito L; Scholten JD; Mulder T
    J Cosmet Sci; 2013; 64(6):445-53. PubMed ID: 24397882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical and instrumental approaches to treat hyperpigmentation.
    Briganti S; Camera E; Picardo M
    Pigment Cell Res; 2003 Apr; 16(2):101-10. PubMed ID: 12622786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethyl acetate extract from Panax ginseng C.A. Meyer and its main constituents inhibit α-melanocyte-stimulating hormone-induced melanogenesis by suppressing oxidative stress in B16 mouse melanoma cells.
    Jiang R; Xu XH; Wang K; Yang XZ; Bi YF; Yan Y; Liu JZ; Chen XN; Wang ZZ; Guo XL; Zhao DQ; Sun LW
    J Ethnopharmacol; 2017 Aug; 208():149-156. PubMed ID: 28689798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.